Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 7:51 pm Sale | 2024-09-30 | 13G | HEALTH CATALYST INC HCAT | Point72 Asset Management L.P. | 619,020 1.000% | -3,540,434 (-85.12%) | Filing History |
| 2024-11-14 7:51 pm Sale | 2024-09-30 | 13G | CYBIN INC HELP | Point72 Asset Management L.P. | 292,397 1.400% | -29,768,715 (-99.03%) | Filing History |
| 2024-11-14 7:50 pm Sale | 2024-09-30 | 13G | ARCUTIS BIOTHERAPEUTICS INC CO ARQT | Point72 Asset Management L.P. | 247,055 0.200% | -4,620,651 (-94.92%) | Filing History |
| 2024-11-14 7:50 pm Sale | 2024-09-30 | 13G | ELEVATION ONCOLOGY INC ELEV | Point72 Asset Management L.P. | 500,000 0.800% | -3,540,000 (-87.62%) | Filing History |
| 2024-11-14 7:50 pm Sale | 2024-09-30 | 13G | FATE THERAPEUTICS INC FATE | Point72 Asset Management L.P. | 0 0.000% | -4,945,146 (Position Closed) | Filing History |
| 2024-11-14 7:49 pm Sale | 2024-09-30 | 13G | TPI COMPOSITES INC TPICQ | Point72 Asset Management L.P. | 931,606 2.000% | -2,354,716 (-71.65%) | Filing History |
| 2024-11-14 7:49 pm Sale | 2024-09-30 | 13G | MARAVAI LIFESCIENCES HLDGS INC MRVI | Point72 Asset Management L.P. | 3,687,127 2.600% | -2,959,888 (-44.53%) | Filing History |
| 2024-11-14 7:49 pm Purchase | 2024-09-30 | 13G | PAGSEGURO DIGITAL LTD PAGS | Point72 Asset Management L.P. | 15,861,279 7.600% | 4,927,669 (+45.07%) | Filing History |
| 2024-11-14 7:48 pm Sale | 2024-09-30 | 13G | LYRA THERAPEUTICS INC LYRA | Point72 Asset Management L.P. | 0 0.000% | -60,606 (Position Closed) | Filing History |
| 2024-11-14 7:48 pm Sale | 2024-09-30 | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | Point72 Asset Management L.P. | 0 0.000% | -388,676 (Position Closed) | Filing History |
| 2024-11-14 7:47 pm Sale | 2024-09-30 | 13G | PULMONX CORP LUNG | Point72 Asset Management L.P. | 0 0.000% | -1,936,083 (Position Closed) | Filing History |
| 2024-11-14 7:47 pm Sale | 2024-09-30 | 13G | CELLDEX THERAPEUTICS INC C CLDX | Point72 Asset Management L.P. | 1,684,032 2.500% | -1,072,090 (-38.90%) | Filing History |
| 2024-11-14 7:46 pm Sale | 2024-09-30 | 13G | UROGEN PHARMA LTD URGN | Point72 Asset Management L.P. | 1,520,007 3.600% | -1,049,819 (-40.85%) | Filing History |
| 2024-10-23 6:01 pm Purchase | 2024-10-16 | 13G | BRIGHT MINDS BIOSCIENCES INC C DRUG | Point72 Asset Management L.P. | 435,000 9.700% | 435,000 (New Position) | Filing History |
| 2024-10-21 5:05 pm Purchase | 2024-10-18 | 13G | SHOALS TECHNOLOGIES GROUP INC SHLS | Point72 Asset Management L.P. | 9,029,023 5.400% | 9,029,023 (New Position) | Filing History |
| 2024-10-15 5:01 pm Purchase | 2024-10-14 | 13G | ATYR PHARMA INC ATYR | Point72 Asset Management L.P. | 5,039,846 6.200% | 5,039,846 (New Position) | Filing History |
| 2024-10-10 4:10 pm Purchase | 2024-10-09 | 13G | INHIBIKASE THERAPEUTICS INC CO IKT | Point72 Asset Management L.P. | 625,000 8.400% | 625,000 (New Position) | Filing History |
| 2024-09-05 4:36 pm Purchase | 2024-09-04 | 13G | TELADOC HEALTH, INC. TDOC | Point72 Asset Management L.P. | 8,754,723 5.100% | 8,754,723 (New Position) | Filing History |
| 2024-07-02 6:10 pm Purchase | 2024-07-01 | 13G | LUMENTUM HLGDS INC LITE | Point72 Asset Management L.P. | 3,382,398 5.000% | 3,382,398 (New Position) | Filing History |
| 2024-06-24 4:51 pm Purchase | 2024-06-14 | 13G | UROGEN PHARMA LTD URGN | Point72 Asset Management L.P. | 2,569,826 6.200% | 2,569,826 (New Position) | Filing History |